Results 101 to 110 of about 28,806 (223)

Seroprotection to vaccine‐preventable diseases among workers at a Victorian tertiary hospital

Australian and New Zealand Journal of Public Health, 2016
Objective: To determine seroprotection for the vaccine‐preventable diseases (VPDs) measles, mumps, rubella, varicella and hepatitis B among new employees seen at a Victorian tertiary hospital staff clinic.
Eden C. Andrew, Katherine B. Gibney, Justin Denholm, Karin Leder   +3 more
doaj   +1 more source

Illness after measles-mumps-rubella vaccination.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1993
To provide accurate information on the common sequelae of measles-mumps-rubella (MMR) vaccination and to compare post-vaccine symptoms in children vaccinated at 13 and 15 months.Prospective cluster randomized controlled trial.Twenty-two family practices in southwestern Ontario.All 376 infants who were due to receive MMR vaccine in the next year, 253 ...
T R, Freeman, M A, Stewart, L, Turner
openaire   +1 more source

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy

Vaccines
Background: Despite the efforts of the World Health Organization, some childhood viral diseases, for which there is already an effective vaccine, have not yet been eradicated. Among these, we find varicella, mumps, measles, and rubella, which although in
Brunella Perfetto, Giovanna Paduano, Elena Grimaldi, Vincenza Sansone, Giovanna Donnarumma, Gabriella Di Giuseppe   +5 more
doaj   +1 more source

Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]

Oman Med J, 2022
Al-Mendalawi MD.
europepmc   +1 more source

Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study. [PDF]

Cureus, 2023
Surani AS, Un R, Marfatia Y.
europepmc   +1 more source

Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination

Human Vaccines & Immunotherapeutics
This study compared the immunogenicity of the measles-mumps-rubella (MMR) vaccine when administered alone versus when co-administered with the rotavirus vaccine in infants aged 8–9 months.
Xue-Feng Liang, Xiao-Shu Zhang, Jing An, Yu Tang   +3 more
doaj   +1 more source

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. [PDF]

MMWR Morb Mortal Wkly Rep, 2022
Krow-Lucal E, Marin M, Shepersky L, Bahta L, Loehr J, Dooling K.   +5 more
europepmc   +1 more source

Imunizações e Hipersensibilidade a Proteínas de Ovo [PDF]

, 1998
A segurança da administração da vacina do sarampo em indivíduos com hipersensibilidade ao ovo tem sido motivo de controvérsia, dado o receio de uma eventual reacção anafiláctica após a vacina, uma vez que o vírus vivo atenuado utilizado em algumas ...
Agro, J, Carvalho, F, Morais-Almeida, M, Rosado-Pinto, J   +3 more
core  

Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study

Vaccines
In 2014, the Expanded Program on Immunization of Thailand changed the timing of the second dose of the measles–mumps–rubella (MMR) vaccine from 4–6 years to 2.5 years, while maintaining the first dose at 9 months of age.
Nasiri Sarawanangkoor, Nasamon Wanlapakorn, Donchida Srimuan, Thaksaporn Thatsanathorn, Thanunrat Thongmee, Yong Poovorawan   +5 more
doaj   +1 more source

Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature. [PDF]

Sultan Qaboos Univ Med J, 2022
Al-Qassabi AM, Al-Farsi F.
europepmc   +1 more source